64 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
. Neither the Company nor any Subsidiary has received notice of any investigation or proceedings which, if decided adversely to the Company … knowledge, threatened administrative, regulatory or judicial action, claim or notice of noncompliance or violation, investigation or proceedings
S-3ASR
EX-4.3
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction … such further inquiry or investigation into such facts or matters as it may see fit.
(h) The Trustee shall not be deemed to have notice of any Default
8-K
EX-1.2
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
and the indemnities set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made
8-K
EX-1.1
f1rvtfuch7er
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.2
f4d4zxaz rsqngd2v0
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
zica gz7ujwexggdeg8x
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
khuvhk9la8w 5m
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
f8j r07el
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.3
eu2ktwi
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.2
3b9y2t920jf
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.1
uxsn j916f8qj
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-1.1
76n38ni6
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-4.1
uho7x50a6ul1nr9
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-4.2
lxh8abbswnnhwt
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
b7vxsz3b5ansg yf27u
30 Mar 22
Prospectus supplement for primary offering
5:21pm